The USFDA has approved Novartis' Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients with two years age and more. The first interleukin-1 beta inhibitor is the only treatment approved ...
The US government has filed a civil fraud lawsuit against Novartis claiming the company made illegal payments to induce pharmacies to switch kidney transplant patients to its immunosuppressant drug Myfortic. Civil fraud lawsuit claimed ...
Tags: Civil Fraud Lawsuit, Health, Healthcare Scam
The National Institute for Health and Clinical Excellence (NICE) in the UK, has recommended Novartis' Lucentis (ranibizumab) be approved for use in the National Health Service (NHS) in England and Wales. Ranibizumab is used to treat ...
H7N9 is a serotype of the species Influenzavirus A (avian influenza virus or bird flu virus). H7 normally circulates amongst avian populations with some variants known to occasionally infect humans. An H7N9 virus was first reported to have ...
Clinigen has acquired Cardioxane (dexrazoxane) from Novartis for $33m, which is payable in two tranches. As per the agreement, Clinigen will manufacture, register, distribute, and commercialize the product in countries where current ...
Tags: Clinigen, Cardioxane, Medicine
The Indian Supreme Court has rejected Novartis' patent application for its anti-cancer drug Glivec (imatinib mesylate) saying that “application for patent on the beta-crystalline salt does not meet any standard of novelty or ...
Tags: Indian Apex, Novartis'Patent Plea, Glivec
c (tobramycin inhalation powder) 28mg per capsule has obtained FDA approval for the treatment of bacterial lung infection in certain cystic fibrosis (CF) patients. TOBI Podhaler is new non-nebulized formulation and delivery system of ...
The National Institute for Health and Clinical Excellence (NICE) in the UK, has issued an Appraisal Consultation Document (ACD) recommending that Afinitor (everolimus), a Novartis’ life extending advanced breast cancer treatment ...
The European Commission has approved ThromboGenics' Jetrea (ocriplasmin) for the treatment of vitreomacular traction (VMT), including when coupled with macular hole of diameter less than or equal to 400 microns, in the European Union (EU). ...
Tags: ThromboGenics Jetrea, vitreomacular traction treatment, drug
India-based global pharmaceutical company Dr. Reddy's Laboratories has launched Zoledronic Acid injection (4 mg/5 mL), following the approval of its abbreviated new drug application (ANDA) from the Food and Drug Administration, in the US. ...
Tags: pharmaceutical company, pharmaceutical services, pharmaceutical
The USFDA has approved Novartis Zortress as the first drug to prevent organ rejection in adult patients receiving liver transplantation in the US. The approval was based on positive data from liver transplant study that compared Zortress ...
Tags: medication, FDA, Zortress
Novartis Consumer Health has announced that it is voluntarily recalling certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactured in the United States before December 2011. Novartis Consumer Health has ...
Tags: tamper evident seal, bottle sizes, bottle
US-based Novartis Consumer Health, (NCH) is voluntarily recalling certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups, which were manufactured in the US prior to 31 December 2011. The company has decided to issue a ...
Revenues at BT Group dropped in the three months to 31 December 2012, according to a statement released today, but the firm still managed to produce a profit thanks to cost cutting and lower operating costs. The statement presented ...
Tags: BT Group, operating costs, revenues
Novartis Consumer Health has recalled 2.3 million containers of Triaminic and Theraflu Warming Relief syrups because the child-resistant caps can be removed by children with the tamper-evident seal still in place, posing a poisoning risk. ...
Tags: Novartis Consumer Health, recall, Triaminic and Theraflu Warming Relief